A detailed history of Squarepoint Ops LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 331,707 shares of PTCT stock, worth $14.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
331,707
Previous 122,890 169.92%
Holding current value
$14.3 Million
Previous $3.76 Million 227.55%
% of portfolio
0.02%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.39 - $37.66 $6.35 Million - $7.86 Million
208,817 Added 169.92%
331,707 $12.3 Million
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $3.03 Million - $4.93 Million
122,890 New
122,890 $3.76 Million
Q4 2022

Feb 14, 2023

SELL
$33.53 - $54.79 $2.5 Million - $4.08 Million
-74,456 Reduced 53.4%
64,967 $2.48 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $2.08 Million - $2.67 Million
49,584 Added 55.19%
139,423 $7 Million
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $1.1 Million - $1.94 Million
42,783 Added 90.92%
89,839 $3.6 Million
Q1 2022

May 16, 2022

BUY
$33.33 - $44.6 $1.57 Million - $2.1 Million
47,056 New
47,056 $1.76 Million
Q2 2021

Aug 16, 2021

SELL
$37.95 - $49.37 $237,984 - $309,599
-6,271 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $293,482 - $432,197
6,271 New
6,271 $297,000
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $654,078 - $922,474
-13,638 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$45.41 - $57.07 $368,229 - $462,780
8,109 Added 146.66%
13,638 $638,000
Q2 2020

Aug 14, 2020

SELL
$42.56 - $54.98 $184,114 - $237,843
-4,326 Reduced 43.9%
5,529 $281,000
Q1 2020

May 15, 2020

BUY
$32.37 - $59.36 $319,006 - $584,992
9,855 New
9,855 $440,000
Q4 2019

Feb 14, 2020

SELL
$32.22 - $50.07 $954,130 - $1.48 Million
-29,613 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$33.82 - $48.17 $1 Million - $1.43 Million
29,613 New
29,613 $1 Million
Q2 2019

Aug 14, 2019

SELL
$35.42 - $45.0 $1.44 Million - $1.83 Million
-40,685 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$28.09 - $39.49 $45,000 - $63,262
-1,602 Reduced 3.79%
40,685 $1.53 Million
Q4 2018

Feb 14, 2019

BUY
$29.83 - $46.51 $390,385 - $608,676
13,087 Added 44.82%
42,287 $1.45 Million
Q3 2018

Nov 14, 2018

SELL
$33.9 - $47.77 $439,242 - $618,955
-12,957 Reduced 30.74%
29,200 $1.37 Million
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $320,736 - $597,542
12,480 Added 42.05%
42,157 $1.42 Million
Q1 2018

May 15, 2018

BUY
$17.46 - $32.59 $5,936 - $11,080
340 Added 1.16%
29,677 $803,000
Q4 2017

Feb 14, 2018

BUY
$15.14 - $20.89 $444,162 - $612,849
29,337
29,337 $489,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.09B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.